-
1
-
-
0034110023
-
Epidemiology, aetiology, and prognosis of heart failure
-
McMurray J.J., Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart May 2000, 83(5):596-602.
-
(2000)
Heart
, vol.83
, Issue.5
, pp. 596-602
-
-
McMurray, J.J.1
Stewart, S.2
-
2
-
-
84857036974
-
Recent advances in the management of chronic heart failure
-
Haddad H., Mielniczuk L., Davies R.A. Recent advances in the management of chronic heart failure. Curr Opin Cardiol Mar 2012, 27(2):161-168.
-
(2012)
Curr Opin Cardiol
, vol.27
, Issue.2
, pp. 161-168
-
-
Haddad, H.1
Mielniczuk, L.2
Davies, R.A.3
-
3
-
-
0037058826
-
Lifetime risk for developing congestive heart failure: the Framingham Heart Study
-
Lloyd-Jones D.M., Larson M.G., Leip E.P., Beiser A., D'Agostino R.B., Kannel W.B., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation Dec 10 2002, 106(24):3068-3072.
-
(2002)
Circulation
, vol.106
, Issue.24
, pp. 3068-3072
-
-
Lloyd-Jones, D.M.1
Larson, M.G.2
Leip, E.P.3
Beiser, A.4
D'Agostino, R.B.5
Kannel, W.B.6
-
4
-
-
69049099994
-
Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives
-
Neumann T., Biermann J., Erbel R., Neumann A., Wasem J., Ertl G., et al. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int Apr 2009, 106(16):269-275.
-
(2009)
Dtsch Arztebl Int
, vol.106
, Issue.16
, pp. 269-275
-
-
Neumann, T.1
Biermann, J.2
Erbel, R.3
Neumann, A.4
Wasem, J.5
Ertl, G.6
-
5
-
-
77649091020
-
Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association
-
Lloyd-Jones D., Adams R.J., Brown T.M., Carnethon M., Dai S., De Simone G., et al. Executive summary: heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation Feb 23 2010, 121(7):948-954.
-
(2010)
Circulation
, vol.121
, Issue.7
, pp. 948-954
-
-
Lloyd-Jones, D.1
Adams, R.J.2
Brown, T.M.3
Carnethon, M.4
Dai, S.5
De Simone, G.6
-
6
-
-
84872172492
-
Aging of the United States population: impact on heart failure
-
Vigen R., Maddox T.M., Allen L.A. Aging of the United States population: impact on heart failure. Curr Heart Fail Rep Dec 2012, 9(4):369-374.
-
(2012)
Curr Heart Fail Rep
, vol.9
, Issue.4
, pp. 369-374
-
-
Vigen, R.1
Maddox, T.M.2
Allen, L.A.3
-
7
-
-
84879202874
-
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association
-
Heidenreich P.A., Albert N.M., Allen L.A., Bluemke D.A., Butler J., Fonarow G.C., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail May 2013, 6(3):606-619.
-
(2013)
Circ Heart Fail
, vol.6
, Issue.3
, pp. 606-619
-
-
Heidenreich, P.A.1
Albert, N.M.2
Allen, L.A.3
Bluemke, D.A.4
Butler, J.5
Fonarow, G.C.6
-
8
-
-
84877246724
-
Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH
-
van der Velde A.R., Gullestad L., Ueland T., Aukrust P., Guo Y., Adourian A., et al. Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH. Circ Heart Fail Mar 2013, 6(2):219-226.
-
(2013)
Circ Heart Fail
, vol.6
, Issue.2
, pp. 219-226
-
-
van der Velde, A.R.1
Gullestad, L.2
Ueland, T.3
Aukrust, P.4
Guo, Y.5
Adourian, A.6
-
9
-
-
76449120415
-
N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study
-
Berger R., Moertl D., Peter S., Ahmadi R., Huelsmann M., Yamuti S., et al. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study. J Am Coll Cardiol Feb 16 2010, 55(7):645-653.
-
(2010)
J Am Coll Cardiol
, vol.55
, Issue.7
, pp. 645-653
-
-
Berger, R.1
Moertl, D.2
Peter, S.3
Ahmadi, R.4
Huelsmann, M.5
Yamuti, S.6
-
10
-
-
84864477617
-
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Bohm M., Dickstein K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail Aug 2012, 14(8):803-869.
-
(2012)
Eur J Heart Fail
, vol.14
, Issue.8
, pp. 803-869
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Bohm, M.5
Dickstein, K.6
-
11
-
-
0037374349
-
B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study
-
McCullough P.A., Duc P., Omland T., McCord J., Nowak R.M., Hollander J.E., et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis Mar 2003, 41(3):571-579.
-
(2003)
Am J Kidney Dis
, vol.41
, Issue.3
, pp. 571-579
-
-
McCullough, P.A.1
Duc, P.2
Omland, T.3
McCord, J.4
Nowak, R.M.5
Hollander, J.E.6
-
12
-
-
1042267237
-
Impact of obesity on plasma natriuretic peptide levels
-
Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Wilson P.W., et al. Impact of obesity on plasma natriuretic peptide levels. Circulation Feb 10 2004, 109(5):594-600.
-
(2004)
Circulation
, vol.109
, Issue.5
, pp. 594-600
-
-
Wang, T.J.1
Larson, M.G.2
Levy, D.3
Benjamin, E.J.4
Leip, E.P.5
Wilson, P.W.6
-
13
-
-
2342443071
-
Obesity and suppressed B-type natriuretic peptide levels in heart failure
-
Mehra M.R., Uber P.A., Park M.H., Scott R.L., Ventura H.O., Harris B.C., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol May 5 2004, 43(9):1590-1595.
-
(2004)
J Am Coll Cardiol
, vol.43
, Issue.9
, pp. 1590-1595
-
-
Mehra, M.R.1
Uber, P.A.2
Park, M.H.3
Scott, R.L.4
Ventura, H.O.5
Harris, B.C.6
-
14
-
-
69249134131
-
Galectin-3: a novel mediator of heart failure development and progression
-
de Boer R.A., Voors A.A., Muntendam P., van Gilst W.H., van Veldhuisen D.J. Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail Sep 2009, 11(9):811-817.
-
(2009)
Eur J Heart Fail
, vol.11
, Issue.9
, pp. 811-817
-
-
de Boer, R.A.1
Voors, A.A.2
Muntendam, P.3
van Gilst, W.H.4
van Veldhuisen, D.J.5
-
15
-
-
0031231651
-
Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22
-
Raimond J., Zimonjic D.B., Mignon C., Mattei M., Popescu N.C., Monsigny M., et al. Mapping of the galectin-3 gene (LGALS3) to human chromosome 14 at region 14q21-22. Mamm Genome Sep 1997, 8(9):706-707.
-
(1997)
Mamm Genome
, vol.8
, Issue.9
, pp. 706-707
-
-
Raimond, J.1
Zimonjic, D.B.2
Mignon, C.3
Mattei, M.4
Popescu, N.C.5
Monsigny, M.6
-
17
-
-
0028874589
-
Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages
-
Liu F.T., Hsu D.K., Zuberi R.I., Kuwabara I., Chi E.Y., Henderson W.R. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am J Pathol Oct 1995, 147(4):1016-1028.
-
(1995)
Am J Pathol
, vol.147
, Issue.4
, pp. 1016-1028
-
-
Liu, F.T.1
Hsu, D.K.2
Zuberi, R.I.3
Kuwabara, I.4
Chi, E.Y.5
Henderson, W.R.6
-
18
-
-
67649831425
-
The regulation of inflammation by galectin-3
-
Henderson N.C., Sethi T. The regulation of inflammation by galectin-3. Immunol Rev Jul 2009, 230(1):160-171.
-
(2009)
Immunol Rev
, vol.230
, Issue.1
, pp. 160-171
-
-
Henderson, N.C.1
Sethi, T.2
-
19
-
-
33847347313
-
ECM remodeling in hypertensive heart disease
-
Berk B.C., Fujiwara K., Lehoux S. ECM remodeling in hypertensive heart disease. J Clin Invest Mar 2007, 117(3):568-575.
-
(2007)
J Clin Invest
, vol.117
, Issue.3
, pp. 568-575
-
-
Berk, B.C.1
Fujiwara, K.2
Lehoux, S.3
-
20
-
-
84887625229
-
Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction
-
Carrasco-Sanchez F.J., Aramburu-Bodas O., Salamanca-Bautista P., Morales-Rull J.L., Galisteo-Almeda L., Paez-Rubio M.I., et al. Predictive value of serum galectin-3 levels in patients with acute heart failure with preserved ejection fraction. Int J Cardiol Nov 5 2013, 169(3):177-182.
-
(2013)
Int J Cardiol
, vol.169
, Issue.3
, pp. 177-182
-
-
Carrasco-Sanchez, F.J.1
Aramburu-Bodas, O.2
Salamanca-Bautista, P.3
Morales-Rull, J.L.4
Galisteo-Almeda, L.5
Paez-Rubio, M.I.6
-
21
-
-
20844462878
-
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
-
Sharma U.C., Pokharel S., van Brakel T.J., van Berlo J.H., Cleutjens J.P., Schroen B., et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation Nov 9 2004, 110(19):3121-3128.
-
(2004)
Circulation
, vol.110
, Issue.19
, pp. 3121-3128
-
-
Sharma, U.C.1
Pokharel, S.2
van Brakel, T.J.3
van Berlo, J.H.4
Cleutjens, J.P.5
Schroen, B.6
-
22
-
-
61949375975
-
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
-
Liu Y.H., D'Ambrosio M., Liao T.D., Peng H., Rhaleb N.E., Sharma U., et al. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin. Am J Physiol Heart Circ Physiol Feb 2009, 296(2):H404-H412.
-
(2009)
Am J Physiol Heart Circ Physiol
, vol.296
, Issue.2
, pp. H404-H412
-
-
Liu, Y.H.1
D'Ambrosio, M.2
Liao, T.D.3
Peng, H.4
Rhaleb, N.E.5
Sharma, U.6
-
23
-
-
84873622349
-
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis
-
Yu L., Ruifrok W.P., Meissner M., Bos E.M., van Goor H., Sanjabi B., et al. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis. Circ Heart Fail Jan 2013, 6(1):107-117.
-
(2013)
Circ Heart Fail
, vol.6
, Issue.1
, pp. 107-117
-
-
Yu, L.1
Ruifrok, W.P.2
Meissner, M.3
Bos, E.M.4
van Goor, H.5
Sanjabi, B.6
-
24
-
-
84894072317
-
Galectin-3 expression in cardiac remodeling after myocardial infarction
-
Sanchez-Mas J., Lax A., Asensio-Lopez M.C., Fernandez-Del Palacio M.J., Caballero L., Garrido I.P., et al. Galectin-3 expression in cardiac remodeling after myocardial infarction. Int J Cardiol Mar 1 2014, 172(1):e98-e101.
-
(2014)
Int J Cardiol
, vol.172
, Issue.1
, pp. e98-e101
-
-
Sanchez-Mas, J.1
Lax, A.2
Asensio-Lopez, M.C.3
Fernandez-Del Palacio, M.J.4
Caballero, L.5
Garrido, I.P.6
-
25
-
-
84871813952
-
Galectin-3 mediates aldosterone-induced vascular fibrosis
-
Calvier L., Miana M., Reboul P., Cachofeiro V., Martinez-Martinez E., de Boer R.A., et al. Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler Thromb Vasc Biol Jan 2013, 33(1):67-75.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, Issue.1
, pp. 67-75
-
-
Calvier, L.1
Miana, M.2
Reboul, P.3
Cachofeiro, V.4
Martinez-Martinez, E.5
de Boer, R.A.6
-
26
-
-
33645533798
-
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
-
Henderson N.C., Mackinnon A.C., Farnworth S.L., Poirier F., Russo F.P., Iredale J.P., et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A Mar 28 2006, 103(13):5060-5065.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, Issue.13
, pp. 5060-5065
-
-
Henderson, N.C.1
Mackinnon, A.C.2
Farnworth, S.L.3
Poirier, F.4
Russo, F.P.5
Iredale, J.P.6
-
27
-
-
39549100788
-
Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis
-
Henderson N.C., Mackinnon A.C., Farnworth S.L., Kipari T., Haslett C., Iredale J.P., et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol Feb 2008, 172(2):288-298.
-
(2008)
Am J Pathol
, vol.172
, Issue.2
, pp. 288-298
-
-
Henderson, N.C.1
Mackinnon, A.C.2
Farnworth, S.L.3
Kipari, T.4
Haslett, C.5
Iredale, J.P.6
-
28
-
-
84857881755
-
Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3
-
Mackinnon A.C., Gibbons M.A., Farnworth S.L., Leffler H., Nilsson U.J., Delaine T., et al. Regulation of transforming growth factor-beta1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med Mar 1 2012, 185(5):537-546.
-
(2012)
Am J Respir Crit Care Med
, vol.185
, Issue.5
, pp. 537-546
-
-
Mackinnon, A.C.1
Gibbons, M.A.2
Farnworth, S.L.3
Leffler, H.4
Nilsson, U.J.5
Delaine, T.6
-
29
-
-
77951206972
-
Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure
-
Christenson R.H., Duh S.H., Wu A.H., Smith A., Abel G., deFilippi C.R., et al. Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. Clin Biochem May 2010, 43(7-8):683-690.
-
(2010)
Clin Biochem
, vol.43
, Issue.7-8
, pp. 683-690
-
-
Christenson, R.H.1
Duh, S.H.2
Wu, A.H.3
Smith, A.4
Abel, G.5
deFilippi, C.R.6
-
30
-
-
84896902187
-
The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure
-
Meijers W.C., van der Velde A.R., de Boer R.A. The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure. Expert Rev Mol Diagn 2014, 14(3):257-266.
-
(2014)
Expert Rev Mol Diagn
, vol.14
, Issue.3
, pp. 257-266
-
-
Meijers, W.C.1
van der Velde, A.R.2
de Boer, R.A.3
-
31
-
-
84891696028
-
Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fraction
-
Gruson D., Mancini M., Ahn S.A., Rousseau M.F. Galectin-3 testing: validity of a novel automated assay in heart failure patients with reduced ejection fraction. Clin Chim Acta Feb 15 2014, 429:189-193.
-
(2014)
Clin Chim Acta
, vol.429
, pp. 189-193
-
-
Gruson, D.1
Mancini, M.2
Ahn, S.A.3
Rousseau, M.F.4
-
32
-
-
84879467972
-
Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)
-
Maggioni A.P., Dahlström U., Filippatos G., Chioncel O., Crespo Leiro M., Drozdz J., et al. Heart Failure Association of the European Society of Cardiology (HFA). EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013, 15(7):808-817.
-
(2013)
Eur J Heart Fail
, vol.15
, Issue.7
, pp. 808-817
-
-
Maggioni, A.P.1
Dahlström, U.2
Filippatos, G.3
Chioncel, O.4
Crespo Leiro, M.5
Drozdz, J.6
-
33
-
-
33751059230
-
Congestion in acute heart failure syndromes: an essential target of evaluation and treatment
-
Gheorghiade M., Filippatos G., De Luca L., Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med Dec 2006, 119(12 Suppl 1):S3-S10.
-
(2006)
Am J Med
, vol.119
, Issue.12
, pp. S3-S10
-
-
Gheorghiade, M.1
Filippatos, G.2
De Luca, L.3
Burnett, J.4
-
34
-
-
84871912144
-
Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization
-
Collins S.P., Pang P.S., Fonarow G.C., Yancy C.W., Bonow R.O., Gheorghiade M. Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol Jan 15 2013, 61(2):121-126.
-
(2013)
J Am Coll Cardiol
, vol.61
, Issue.2
, pp. 121-126
-
-
Collins, S.P.1
Pang, P.S.2
Fonarow, G.C.3
Yancy, C.W.4
Bonow, R.O.5
Gheorghiade, M.6
-
35
-
-
84901434162
-
Emergency department use of galectin-3
-
Peacock W.F., DiSomma S. Emergency department use of galectin-3. Crit Pathw Cardiol Jun 2014, 13(2):73-77.
-
(2014)
Crit Pathw Cardiol
, vol.13
, Issue.2
, pp. 73-77
-
-
Peacock, W.F.1
DiSomma, S.2
-
36
-
-
33748415221
-
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure
-
van Kimmenade R.R., Januzzi J.L., Ellinor P.T., Sharma U.C., Bakker J.A., Low A.F., et al. Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol Sep 19 2006, 48(6):1217-1224.
-
(2006)
J Am Coll Cardiol
, vol.48
, Issue.6
, pp. 1217-1224
-
-
van Kimmenade, R.R.1
Januzzi, J.L.2
Ellinor, P.T.3
Sharma, U.C.4
Bakker, J.A.5
Low, A.F.6
-
37
-
-
78651387589
-
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
-
de Boer R.A., Lok D.J., Jaarsma T., van der Meer P., Voors A.A., Hillege H.L., et al. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction. Ann Med Feb 2011, 43(1):60-68.
-
(2011)
Ann Med
, vol.43
, Issue.1
, pp. 60-68
-
-
de Boer, R.A.1
Lok, D.J.2
Jaarsma, T.3
van der Meer, P.4
Voors, A.A.5
Hillege, H.L.6
-
38
-
-
84885058278
-
Galectin-3 in heart failure with preserved ejection fraction
-
de Boer R.A., Edelmann F., Cohen-Solal A., Mamas M.A., Maisel A., Pieske B. Galectin-3 in heart failure with preserved ejection fraction. Eur J Heart Fail 2013, 15(10):1095-1101.
-
(2013)
Eur J Heart Fail
, vol.15
, Issue.10
, pp. 1095-1101
-
-
de Boer, R.A.1
Edelmann, F.2
Cohen-Solal, A.3
Mamas, M.A.4
Maisel, A.5
Pieske, B.6
-
39
-
-
84901780251
-
Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials
-
Meijers W.C., Januzzi J.L., deFilippi C., Adourian A.S., Shah S.J., van Veldhuisen D.J., et al. Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: a pooled analysis of 3 clinical trials. Am Heart J Jun 2014, 167(6):853-860. [e4.].
-
(2014)
Am Heart J
, vol.167
, Issue.6
, pp. 853-860
-
-
Meijers, W.C.1
Januzzi, J.L.2
deFilippi, C.3
Adourian, A.S.4
Shah, S.J.5
van Veldhuisen, D.J.6
-
40
-
-
84867578067
-
Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score
-
Eurlings L.W., Sanders-van Wijk S., van Kimmenade R., Osinski A., van Helmond L., Vallinga M., et al. Multimarker strategy for short-term risk assessment in patients with dyspnea in the emergency department: the MARKED (Multi mARKer Emergency Dyspnea)-risk score. J Am Coll Cardiol Oct 23 2012, 60(17):1668-1677.
-
(2012)
J Am Coll Cardiol
, vol.60
, Issue.17
, pp. 1668-1677
-
-
Eurlings, L.W.1
Sanders-van Wijk, S.2
van Kimmenade, R.3
Osinski, A.4
van Helmond, L.5
Vallinga, M.6
-
41
-
-
84870482586
-
Galectin 3 complements BNP in risk stratification in acute heart failure
-
Fermann G.J., Lindsell C.J., Storrow A.B., Hart K., Sperling M., Roll S., et al. Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers Dec 2012, 17(8):706-713.
-
(2012)
Biomarkers
, vol.17
, Issue.8
, pp. 706-713
-
-
Fermann, G.J.1
Lindsell, C.J.2
Storrow, A.B.3
Hart, K.4
Sperling, M.5
Roll, S.6
-
42
-
-
84904801975
-
Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure
-
De Berardinis B., Magrini L., Zampini G., Zancla B., Salerno G., Cardelli P., et al. Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure. Biomed Res Int 2014, 2014:983098.
-
(2014)
Biomed Res Int
, vol.2014
, pp. 983098
-
-
De Berardinis, B.1
Magrini, L.2
Zampini, G.3
Zancla, B.4
Salerno, G.5
Cardelli, P.6
-
43
-
-
84880072700
-
Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results
-
Wu A.H., Wians F., Jaffe A. Biological variation of galectin-3 and soluble ST2 for chronic heart failure: implication on interpretation of test results. Am Heart J Jun 2013, 165(6):995-999.
-
(2013)
Am Heart J
, vol.165
, Issue.6
, pp. 995-999
-
-
Wu, A.H.1
Wians, F.2
Jaffe, A.3
-
44
-
-
84877106997
-
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
-
Anand I.S., Rector T.S., Kuskowski M., Adourian A., Muntendam P., Cohn J.N. Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT. Eur J Heart Fail May 2013, 15(5):511-518.
-
(2013)
Eur J Heart Fail
, vol.15
, Issue.5
, pp. 511-518
-
-
Anand, I.S.1
Rector, T.S.2
Kuskowski, M.3
Adourian, A.4
Muntendam, P.5
Cohn, J.N.6
-
45
-
-
84885044150
-
Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study
-
Motiwala S.R., Szymonifka J., Belcher A., Weiner R.B., Baggish A.L., Sluss P., et al. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail Oct 2013, 15(10):1157-1163.
-
(2013)
Eur J Heart Fail
, vol.15
, Issue.10
, pp. 1157-1163
-
-
Motiwala, S.R.1
Szymonifka, J.2
Belcher, A.3
Weiner, R.B.4
Baggish, A.L.5
Sluss, P.6
-
46
-
-
70349975735
-
The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients
-
Lin Y.H., Lin L.Y., Wu Y.W., Chien K.L., Lee C.M., Hsu R.B., et al. The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta Nov 2009, 409(1-2):96-99.
-
(2009)
Clin Chim Acta
, vol.409
, Issue.1-2
, pp. 96-99
-
-
Lin, Y.H.1
Lin, L.Y.2
Wu, Y.W.3
Chien, K.L.4
Lee, C.M.5
Hsu, R.B.6
-
47
-
-
77954658143
-
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
-
Lok D.J., Van Der Meer P., de la Porte P.W., Lipsic E., Van Wijngaarden J., Hillege H.L., et al. Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol May 2010, 99(5):323-328.
-
(2010)
Clin Res Cardiol
, vol.99
, Issue.5
, pp. 323-328
-
-
Lok, D.J.1
Van Der Meer, P.2
de la Porte, P.W.3
Lipsic, E.4
Van Wijngaarden, J.5
Hillege, H.L.6
-
48
-
-
84876134473
-
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure
-
Lok D.J., Lok S.I., Bruggink-Andre de la Porte P.W., Badings E., Lipsic E., van Wijngaarden J., et al. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol Feb 2013, 102(2):103-110.
-
(2013)
Clin Res Cardiol
, vol.102
, Issue.2
, pp. 103-110
-
-
Lok, D.J.1
Lok, S.I.2
Bruggink-Andre de la Porte, P.W.3
Badings, E.4
Lipsic, E.5
van Wijngaarden, J.6
-
49
-
-
84859639923
-
Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study
-
Felker G.M., Fiuzat M., Shaw L.K., Clare R., Whellan D.J., Bettari L., et al. Galectin-3 in ambulatory patients with heart failure: results from the HF-ACTION study. Circ Heart Fail Jan 2012, 5(1):72-78.
-
(2012)
Circ Heart Fail
, vol.5
, Issue.1
, pp. 72-78
-
-
Felker, G.M.1
Fiuzat, M.2
Shaw, L.K.3
Clare, R.4
Whellan, D.J.5
Bettari, L.6
-
50
-
-
84901658442
-
Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure
-
Ahmad T., Fiuzat M., Neely B., Neely M.L., Pencina M.J., Kraus W.E., et al. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. JACC Heart Fail Jun 2014, 2(3):260-268.
-
(2014)
JACC Heart Fail
, vol.2
, Issue.3
, pp. 260-268
-
-
Ahmad, T.1
Fiuzat, M.2
Neely, B.3
Neely, M.L.4
Pencina, M.J.5
Kraus, W.E.6
-
51
-
-
84870300941
-
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
-
Gullestad L., Ueland T., Kjekshus J., Nymo S.H., Hulthe J., Muntendam P., et al. The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA). Am Heart J Dec 2012, 164(6):878-883.
-
(2012)
Am Heart J
, vol.164
, Issue.6
, pp. 878-883
-
-
Gullestad, L.1
Ueland, T.2
Kjekshus, J.3
Nymo, S.H.4
Hulthe, J.5
Muntendam, P.6
-
52
-
-
79960350455
-
Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival
-
Tang W.H., Shrestha K., Shao Z., Borowski A.G., Troughton R.W., Thomas J.D., et al. Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival. Am J Cardiol Aug 1 2011, 108(3):385-390.
-
(2011)
Am J Cardiol
, vol.108
, Issue.3
, pp. 385-390
-
-
Tang, W.H.1
Shrestha, K.2
Shao, Z.3
Borowski, A.G.4
Troughton, R.W.5
Thomas, J.D.6
-
53
-
-
84892415130
-
Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3
-
Bayes-Genis A., de Antonio M., Vila J., Penafiel J., Galan A., Barallat J., et al. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3. J Am Coll Cardiol Jan 21 2014, 63(2):158-166.
-
(2014)
J Am Coll Cardiol
, vol.63
, Issue.2
, pp. 158-166
-
-
Bayes-Genis, A.1
de Antonio, M.2
Vila, J.3
Penafiel, J.4
Galan, A.5
Barallat, J.6
-
54
-
-
84995363390
-
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population
-
Nieminen M.S., Brutsaert D., Dickstein K., Drexler H., Follath F., Harjola V.P., et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J Nov 2006, 27(22):2725-2736.
-
(2006)
Eur Heart J
, vol.27
, Issue.22
, pp. 2725-2736
-
-
Nieminen, M.S.1
Brutsaert, D.2
Dickstein, K.3
Drexler, H.4
Follath, F.5
Harjola, V.P.6
-
55
-
-
84856072702
-
Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22
-
Grandin E.W., Jarolim P., Murphy S.A., Ritterova L., Cannon C.P., Braunwald E., et al. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. Clin Chem Jan 2012, 58(1):267-273.
-
(2012)
Clin Chem
, vol.58
, Issue.1
, pp. 267-273
-
-
Grandin, E.W.1
Jarolim, P.2
Murphy, S.A.3
Ritterova, L.4
Cannon, C.P.5
Braunwald, E.6
-
56
-
-
84866729958
-
Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community
-
Ho J.E., Liu C., Lyass A., Courchesne P., Pencina M.J., Vasan R.S., et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol Oct 2 2012, 60(14):1249-1256.
-
(2012)
J Am Coll Cardiol
, vol.60
, Issue.14
, pp. 1249-1256
-
-
Ho, J.E.1
Liu, C.2
Lyass, A.3
Courchesne, P.4
Pencina, M.J.5
Vasan, R.S.6
-
57
-
-
84896933305
-
Plasma galectin 3 and heart failure risk in the Physicians' Health Study
-
Djousse L., Matsumoto C., Petrone A., Weir N.L., Tsai M.Y., Gaziano J.M. Plasma galectin 3 and heart failure risk in the Physicians' Health Study. Eur J Heart Fail Mar 2014, 16(3):350-354.
-
(2014)
Eur J Heart Fail
, vol.16
, Issue.3
, pp. 350-354
-
-
Djousse, L.1
Matsumoto, C.2
Petrone, A.3
Weir, N.L.4
Tsai, M.Y.5
Gaziano, J.M.6
-
58
-
-
84920131848
-
Clinical risk stratification optimizes value of biomarkers to predict new onset heart failure in a community-based cohort
-
Brouwers F.P., van Gilst W.H., Damman K., van den Berg M., Gansevoort R.T., Bakker S.J., et al. Clinical risk stratification optimizes value of biomarkers to predict new onset heart failure in a community-based cohort. Circ Heart Fail Sep 2014, 7(5):723-731.
-
(2014)
Circ Heart Fail Sep
, vol.7
, Issue.5
, pp. 723-731
-
-
Brouwers, F.P.1
van Gilst, W.H.2
Damman, K.3
van den Berg, M.4
Gansevoort, R.T.5
Bakker, S.J.6
-
59
-
-
84899539214
-
Galectin 3 and incident atrial fibrillation in the community
-
Ho J.E., Yin X., Levy D., Vasan R.S., Magnani J.W., Ellinor P.T., et al. Galectin 3 and incident atrial fibrillation in the community. Am Heart J May 2014, 167(5):729-734. [e1.].
-
(2014)
Am Heart J
, vol.167
, Issue.5
, pp. 729-734
-
-
Ho, J.E.1
Yin, X.2
Levy, D.3
Vasan, R.S.4
Magnani, J.W.5
Ellinor, P.T.6
-
60
-
-
84899548228
-
Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study
-
Daniels L.B., Clopton P., Laughlin G.A., Maisel A.S., Barrett-Connor E. Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study. Am Heart J May 2014, 167(5):674-682. [e1.].
-
(2014)
Am Heart J
, vol.167
, Issue.5
, pp. 674-682
-
-
Daniels, L.B.1
Clopton, P.2
Laughlin, G.A.3
Maisel, A.S.4
Barrett-Connor, E.5
-
61
-
-
84890354566
-
The association between galectin-3 and clinical parameters in patients with fi rst acute myocardial infarction treated with primary percutaneous coronary angioplasty
-
Szadkowska I., Wlazel R.N., Migala M., Szadkowski K., Zielinska M., Paradowski M., et al. The association between galectin-3 and clinical parameters in patients with fi rst acute myocardial infarction treated with primary percutaneous coronary angioplasty. Cardiol J 2013, 20(6):577-582.
-
(2013)
Cardiol J
, vol.20
, Issue.6
, pp. 577-582
-
-
Szadkowska, I.1
Wlazel, R.N.2
Migala, M.3
Szadkowski, K.4
Zielinska, M.5
Paradowski, M.6
-
62
-
-
84879224849
-
Galectin-3 and cardiac function in survivors of acute myocardial infarction
-
Weir R.A., Petrie C.J., Murphy C.A., Clements S., Steedman T., Miller A.M., et al. Galectin-3 and cardiac function in survivors of acute myocardial infarction. Circ Heart Fail May 2013, 6(3):492-498.
-
(2013)
Circ Heart Fail
, vol.6
, Issue.3
, pp. 492-498
-
-
Weir, R.A.1
Petrie, C.J.2
Murphy, C.A.3
Clements, S.4
Steedman, T.5
Miller, A.M.6
-
63
-
-
84876406373
-
Using biomarkers to "guide" heart failure management: current perspectives and future directions
-
Motiwala S.R., Januzzi J.L. Using biomarkers to "guide" heart failure management: current perspectives and future directions. Cardiol Rev May-Jun 2013, 21(3):127-134.
-
(2013)
Cardiol Rev
, vol.21
, Issue.3
, pp. 127-134
-
-
Motiwala, S.R.1
Januzzi, J.L.2
-
64
-
-
84868303470
-
Use of biomarkers to guide outpatient therapy of heart failure
-
DeBeradinis B., Januzzi J.L. Use of biomarkers to guide outpatient therapy of heart failure. Curr Opin Cardiol Nov 2012, 27(6):661-668.
-
(2012)
Curr Opin Cardiol
, vol.27
, Issue.6
, pp. 661-668
-
-
DeBeradinis, B.1
Januzzi, J.L.2
-
65
-
-
84892642395
-
Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION
-
Fiuzat M., Schulte P.J., Felker M., Ahmad T., Neely M., Adams K.F., et al. Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION. J Card Fail Jan 2014, 20(1):38-44.
-
(2014)
J Card Fail
, vol.20
, Issue.1
, pp. 38-44
-
-
Fiuzat, M.1
Schulte, P.J.2
Felker, M.3
Ahmad, T.4
Neely, M.5
Adams, K.F.6
-
66
-
-
84901985918
-
Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators
-
Francia P., Adduci C., Semprini L., Borro M., Ricotta A., Sensini I., et al. Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillators. J Cardiovasc Electrophysiol Jun 2014, 25(6):609-616.
-
(2014)
J Cardiovasc Electrophysiol
, vol.25
, Issue.6
, pp. 609-616
-
-
Francia, P.1
Adduci, C.2
Semprini, L.3
Borro, M.4
Ricotta, A.5
Sensini, I.6
-
67
-
-
84919811777
-
Practical experience using galectin-3 in heart failure
-
McCullough P.A. Practical experience using galectin-3 in heart failure. Clin Chem Lab Med Oct 2014, 52(10):1425-1431.
-
(2014)
Clin Chem Lab Med
, vol.52
, Issue.10
, pp. 1425-1431
-
-
McCullough, P.A.1
-
68
-
-
84884294190
-
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
-
Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Drazner M.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol Oct 15 2013, 62(16):e147-e239.
-
(2013)
J Am Coll Cardiol
, vol.62
, Issue.16
, pp. e147-e239
-
-
Yancy, C.W.1
Jessup, M.2
Bozkurt, B.3
Butler, J.4
Casey, D.E.5
Drazner, M.H.6
-
69
-
-
84884310000
-
Elevated galectin-3 precedes the development of CKD
-
O'Seaghdha C.M., Hwang S.J., Ho J.E., Vasan R.S., Levy D., Fox C.S. Elevated galectin-3 precedes the development of CKD. J Am Soc Nephrol Sep 2013, 24(9):1470-1477.
-
(2013)
J Am Soc Nephrol
, vol.24
, Issue.9
, pp. 1470-1477
-
-
O'Seaghdha, C.M.1
Hwang, S.J.2
Ho, J.E.3
Vasan, R.S.4
Levy, D.5
Fox, C.S.6
-
70
-
-
79954479056
-
Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury
-
Kolatsi-Joannou M., Price K.L., Winyard P.J., Long D.A. Modified citrus pectin reduces galectin-3 expression and disease severity in experimental acute kidney injury. PLoS One Apr 8 2011, 6(4):e18683.
-
(2011)
PLoS One
, vol.6
, Issue.4
, pp. e18683
-
-
Kolatsi-Joannou, M.1
Price, K.L.2
Winyard, P.J.3
Long, D.A.4
-
71
-
-
84924261313
-
Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis
-
Meijers W.C., van der Velde A.R., Ruifrok W.P., Schroten N.F., Dokter M.M., Damman K., et al. Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis. J Am Heart Assoc 2014, 3:e000962.
-
(2014)
J Am Heart Assoc
, vol.3
, pp. e000962
-
-
Meijers, W.C.1
van der Velde, A.R.2
Ruifrok, W.P.3
Schroten, N.F.4
Dokter, M.M.5
Damman, K.6
-
73
-
-
1542373593
-
Expression of galectins in cancer: a critical review
-
van den Brule F., Califice S., Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj J 2004, 19(7-9):537-542.
-
(2004)
Glycoconj J
, vol.19
, Issue.7-9
, pp. 537-542
-
-
van den Brule, F.1
Califice, S.2
Castronovo, V.3
-
74
-
-
11144241063
-
Galectins as modulators of tumour progression
-
Liu F.T., Rabinovich G.A. Galectins as modulators of tumour progression. Nat Rev Cancer Jan 2005, 5(1):29-41.
-
(2005)
Nat Rev Cancer
, vol.5
, Issue.1
, pp. 29-41
-
-
Liu, F.T.1
Rabinovich, G.A.2
-
75
-
-
84921382237
-
The role of glycemia in acute heart failure patients
-
Seferovic J.P., Milinkovic I., Tesic M., Ristic A., Lalic N., Simeunovic D., et al. The role of glycemia in acute heart failure patients. Clin Chem Lab Med Oct 2014, 52(10):1437-1446.
-
(2014)
Clin Chem Lab Med
, vol.52
, Issue.10
, pp. 1437-1446
-
-
Seferovic, J.P.1
Milinkovic, I.2
Tesic, M.3
Ristic, A.4
Lalic, N.5
Simeunovic, D.6
-
76
-
-
84921353607
-
Structural myocardial alterations in diabetes and hypertension: the role of galectin-3
-
Seferovic J.P., Lalic N.M., Floridi F., Tesic M., Seferovic P.M., Giga V., et al. Structural myocardial alterations in diabetes and hypertension: the role of galectin-3. Clin Chem Lab Med Oct 2014, 52(10):1499-1505.
-
(2014)
Clin Chem Lab Med
, vol.52
, Issue.10
, pp. 1499-1505
-
-
Seferovic, J.P.1
Lalic, N.M.2
Floridi, F.3
Tesic, M.4
Seferovic, P.M.5
Giga, V.6
-
77
-
-
84902244318
-
Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure
-
Yin Q.S., Shi B., Dong L., Bi L. Comparative study of galectin-3 and B-type natriuretic peptide as biomarkers for the diagnosis of heart failure. J Geriatr Cardiol Mar 2014, 11(1):79-82.
-
(2014)
J Geriatr Cardiol
, vol.11
, Issue.1
, pp. 79-82
-
-
Yin, Q.S.1
Shi, B.2
Dong, L.3
Bi, L.4
|